Vibliome Therapeutics and AssayQuant Technologies, Inc. Establish Collaborative Relationship

BOZEMAN, Mont. and MARLBOROUGH, Mass., Aug. 2, 2022 /PRNewswire/ — Vibliome Therapeutics, LLC, and AssayQuant Technologies, Inc., announced today that they have entered into an agreement whereby AssayQuant will provide Vibliome access to their proprietary PhosphoSens® Technology for…

Click here to view original post